Actively Recruiting
Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents
Led by NYU Langone Health · Updated on 2025-10-01
440
Participants Needed
1
Research Sites
219 weeks
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor portable air cleaners (PACs) are a novel approach to reduce exposure to PM2.5 and potentially lower blood pressure. The current study is being conducted to provide evidence that PACs reduce PM2.5 exposure and lower systolic blood pressure (SBP) in key patient populations.
CONDITIONS
Official Title
Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-reported nonsmokers living in a nonsmoking household
- Adults living with hypertension from New York City public housing
You will not qualify if you...
- History of major known arrhythmias such as atrial flutter or fibrillation, ventricular tachycardia
- Screening systolic blood pressure 160 mm Hg or higher, or diastolic blood pressure 100 mm Hg or higher
- Change in blood pressure medication regimen in the past 2 weeks or planned change during the first 30 days of the study
- Current smoking or living with someone who smokes indoors
- Planned travel outside New York City for 2 weeks or more in the next 6 months
- Being incarcerated
- Pregnancy
- Unable or unwilling to give consent
- Established cardiovascular disease
- End-stage kidney disease or chronic kidney disease stage IV or receiving dialysis
- Barriers to using technology, such as visual or hearing impairments
- Lung disease requiring oxygen therapy
- Receiving treatment for cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
J
Jonathan Newman
CONTACT
E
Elle Anastasiou Pesante
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here